Clinical Trial Update: A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of GRC 17536 for painful diabetic peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Peripheral Neuropathy

Drugs mentioned

• GRC 17536 (GRC-17536)

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Painful Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED